EUVIMEDEUVIMED entdecken
Crossref

Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis

Wenbin Cai, Le Liu, Xuelian Shi, Yanan Liu, Jin Wang, Xuan Fang iD, Zhipeng Chen, Ding Ai iD, Yi Zhu iD, Xu Zhang iD

Circulation · 09.05.2023 · 147 (19) · 1444-1460

DOI: 10.1161/circulationaha.122.060257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 09.05.2023. Verfasst von Wenbin Cai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Metabolic Diseases, Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Center for …. Hauptthemen laut MEDLINE: Arachidonate 15-Lipoxygenase, Ferroptosis, Myocardial Reperfusion Injury. Die Arbeit wurde bisher 464-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myocardial ischemia-reperfusion (I/R) injury causes cardiac dysfunction to myocardial cell loss and fibrosis. Prevention of cell death is important to protect cardiac function after I/R injury. The process of reperfusion can lead to multiple types of cardiomyocyte death, including necrosis, apoptosis, autophagy, and ferroptosis. However, the time point at which the various modes of cell death occur after reperfusion injury and the mechanisms underlying ferroptosis regulation in cardiomyocytes are still unclear.

Methods

Using a left anterior descending coronary artery ligation mouse model, we sought to investigate the time point at which the various modes of cell death occur after reperfusion injury. To discover the key molecules involved in cardiomyocyte ferroptosis, we performed a metabolomics study. Loss/gain-of-function approaches were used to understand the role of 15-lipoxygenase (Alox15) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (Pgc1α) in myocardial I/R injury.

Results

We found that apoptosis and necrosis occurred in the early phase of I/R injury, and that ferroptosis was the predominant form of cell death during the prolonged reperfusion. Metabolomic profiling of eicosanoids revealed that Alox15 metabolites accumulated in ferroptotic cardiomyocytes. We demonstrated that Alox15 expression was specifically increased in the injured area of the left ventricle below the suture and colocalized with cardiomyocytes. Furthermore, myocardial-specific knockout of Alox15 in mice alleviated I/R injury and restored cardiac function. 15-Hydroperoxyeicosatetraenoic acid (15-HpETE), an intermediate metabolite derived from arachidonic acid by Alox15, was identified as a trigger for cardiomyocyte ferroptosis. We explored the mechanism underlying its effects and found that 15-HpETE promoted the binding of Pgc1α to the ubiquitin ligase ring finger protein 34, leading to its ubiquitin-dependent degradation. Consequently, attenuated mitochondrial biogenesis and abnormal mitochondrial morphology were observed. ML351, a specific inhibitor of Alox15, increased the protein level of Pgc1α, inhibited cardiomyocyte ferroptosis, protected the injured myocardium, and caused cardiac function recovery.

Conclusions

Together, our results established that Alox15/15-HpETE–mediated cardiomyocyte ferroptosis plays an important role in prolonged I/R injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arachidonate 15-LipoxygenaseFerroptosisMyocardial Reperfusion InjuryAnimalsMiceApoptosisArachidonate 12-LipoxygenaseMyocytes, CardiacNecrosisPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaUbiquitinsLipid PeroxidesLeukotrienes

Stichwörter der Autor:innen

15-HpETEML351ferroptosismyocardium

Substanzen

Arachidonate 12-LipoxygenaseArachidonate 15-LipoxygenasePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaUbiquitins15-hydroperoxy-5,8,11,13-eicosatetraenoic acidLipid PeroxidesLeukotrienesAlox15 protein, mouse

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Metabolic Diseases, Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Center for Cardiovascular Diseases, Research Center of Basic Medical Sciences, De…
  • Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, China (X.F.).

ORCID-Profile: Xuan Fang, Ding Ai, Yi Zhu, Xu Zhang

Zitieren

APA

Cai, W., Liu, L., Shi, X., Liu, Y., Wang, J., Fang, X., Chen, Z., Ai, D., Zhu, Y., & Zhang, X. (2023). Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis. Circulation, 147(19), 1444-1460. https://doi.org/10.1161/circulationaha.122.060257

Vancouver

Cai W, Liu L, Shi X, Liu Y, Wang J, Fang X, et al. Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis. Circulation. 2023;147(19):1444-1460. doi:10.1161/circulationaha.122.060257

BibTeX
@article{Cai2023,
  author = {Cai, Wenbin and Liu, Le and Shi, Xuelian and Liu, Yanan and Wang, Jin and Fang, Xuan and Chen, Zhipeng and Ai, Ding and Zhu, Yi and Zhang, Xu},
  title = {Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis},
  journal = {Circulation},
  year = {2023},
  volume = {147},
  number = {19},
  pages = {1444--1460},
  doi = {10.1161/circulationaha.122.060257}
}
Kostenlos starten →